MDCX Stock Analysis: Buy, Sell, or Hold?
MDCX - Medicus Pharma Ltd. Common Stock
$0.26
-0.01 (-5.30%)
▼
5d:
-1.0%
30d:
-30.43%
90d:
-14.2%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When MDCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MDCX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MDCX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MDCX is currently trading at $0.26, which is considered oversold relative to its 30-day fair value range of $0.27 to $0.36.
Technical Outlook: Technically, MDCX is showing sideways momentum. Immediate support is located at $0.24, while resistance sits at $0.37. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.47 (+1638.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDCX is showing sideways momentum. Immediate support is located at $0.24, while resistance sits at $0.37. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.47 (+1638.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.27 -
$0.36
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.3%)
- BULLISH: Trading 1638.5% below Wall St target ($4.47)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.27 -
$0.36
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.24
Resistance Level
$0.37
Current Trend
Sideways
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.68
Wall Street Target
$4.48
(+1638.5%)
Share & Embed Analysis
Last updated: August 24, 2026 8:50 PM ET
Data refreshes hourly during market hours. Next update: 9:50 PM
Data refreshes hourly during market hours. Next update: 9:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDCX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1315 | 43 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$157 | 31 SELL |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$236 | 48 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$277 | 39 SELL |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$388 | 30 SELL |
